Breast Cancer Clinical Trials

Showing 2441-2460 of 4,817 trials

Cardiac MRI Biomarker Testing (GCC 1618)

NCT02688166

This research study can help understand how cardiac changes may occur with radiation therapy to the heart based off measurements obtained through biomarkers and cardiac imaging. Researchers plan to perform cardiac imaging and biomarkers for any cardiac injury. Cardiac magnetic resonance imaging (CMR) provides the ability to quantitatively measure cardiac function and injury. The cardiac biomarkers that will be tested are effective in the diagnosis, risk-stratification, and monitoring of heart failure.

Breast CancerLung Cancer (Non-Small Cell)Thoracic Cancer+2 more

University of Maryland, Baltimore6 participantsStarted Feb 2018

Baltimore, Maryland, United States

Active Not RecruitingPhase 2/3

Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer

NCT01057069

This study aims to compare the response of triple-negative breast cancer with deficient homologous recombination to intensified alkylating chemotherapy versus standard chemotherapy with dose dense AC and/or Docetaxel-Capecitabine.

Breast Cancer

The Netherlands Cancer Institute310 participantsStarted Jan 2010

Alkmaar, Netherlands • Amsterdam, Netherlands • Amsterdam, Netherlands +11 more locations

Cardiac MRI Biomarker Testing (GCC 1618)

Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer

Related Searches

High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer

Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer

Palbociclib and FES PET

A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab

Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled Trial

The Genomic Medicine at VA Study

Trial of Active Immunotherapy With OBI-833 (Globo H-CRM197) in Advanced/Metastatic Gastric, Lung, Colorectal or Breast Cancer Subjects

Rehabilitation Through Hippotherapy for the Management of Women After Primary Treatment of Breast Cancer

Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy

Real-world Study of Pyrotinib in Neoadjuvant Therapy for HER2-positive Breast Cancer

Comparison Between Serratus Anterior Plane Block and Erector Spinae Plane Block for Mastectomy

Fluzoparib in Combination With Chidamide or Camrelizumab for HRD Positive HER2 Negative Advanced Breast Cancer

Pre- Versus Postoperative Accelerated Partial Breast Irradiation

Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer

Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors

Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool

Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer.

Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early Prediction of Chemosensitivity in Liver MBC